Purchase Order HT001416P1391
Award Date 9/1/16
Potential Completion Date 12/29/16
Potential Value $8.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order contract was awarded by the Defense Health Agency to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $846,759.26 contract is for the delivery of blood collection bags and has a completion date of November 30, 2025. Fenwal, Inc. is a foreign-owned, for-profit manufacturer specializing in blood collection, separation, storage, and transfusion products and services. The company has a strong track record of providing critical...
- This federal contract award, valued at $1,062.50, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi. The contract is for the supply of various blood collection and processing products, including blood bags, tubing, solutions, and apheresis equipment, to support transfusion medicine and cell therapy applications for federal agencies such as the Department of Defense, Department of Veterans Affairs, and National Institutes of Health....
- This federal contract award, valued at $1,426.36, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of various medical supplies and equipment, including blood bags, tubing, solutions, apheresis equipment, and other specialized items used in blood banking and biomedical research operations. The contract does not have a set-aside designation, reflecting Fenwal's...
- This is a firm-fixed-price purchase order awarded by the Defense Health Agency, a component of the Department of Defense, to Fenwal, Inc., a global blood technology company and a subsidiary of Fresenius Kabi. The $1,569.00 contract is for the delivery of various blood collection, separation, storage, and transfusion products, including blood bags, tubing, diluting solutions, washing solutions, anticoagulants, extractors, sealers, clips, stands, and transfer sets. Fenwal, Inc. has an extensive...
- This is a definitive contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Fenwal, Inc., a global blood technology company, for the procurement of blood collection bags. The contract has a firm fixed price, a ceiling value of $911,730.34, and an ultimate completion date of September 30, 2020. Fenwal, Inc. has been a registered vendor with the U.S. federal government since 2007 and has established itself as a key supplier to various federal...
- This contract is for the supply of centrifuging bags (NSN 8510785907) to the Defense Logistics Agency Troop Support Medical, a division of the Department of Defense. The contract was awarded to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, for a firm fixed price of $1,010.86. The contract has an ultimate completion date of September 17, 2024, and was awarded on September 12, 2024. This contract does not have a set-aside designation. Fenwal has a long history...
- This federal contract award to Fenwal, Inc., a subsidiary of Fresenius Kabi, was made by the U.S. Army Medical Command (MEDCOM) for the purchase of CPD/ADSOL DBL WB RZ-2000 blood bags and related equipment. The $143,319.60 firm-fixed-price contract has an ultimate completion date of September 30, 2016 and does not have a set-aside designation. Fenwal, a global blood technology company, has established itself as a key supplier to various federal agencies, primarily supporting transfusion medicine...
- This is a federal purchase order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi, for the supply of various blood collection and transfusion-related products and services. The contract, valued at $4,594.60, has an ultimate completion date of October 22, 2024. Fenwal, a global blood technology company, has been a registered vendor with the U.S. federal government since 2007 and has established itself as a key supplier to...
- This is a firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Fenwal, Inc., a subsidiary of Fresenius Kabi, to provide blood bags for the military. The contract has a potential value of $100,519.90 and a completion date of August 31, 2022. Fenwal is a global blood technology company that has received numerous federal contract awards as a prime contractor to provide blood collection, separation, storage, and transfusion...
- This federal contract award, valued at $1,839.04, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of blood packs with anticoagulant (8510030842) and has a completion date of August 14, 2023. Fenwal, a registered federal vendor since 2007, has a strong track record of supporting the U.S. government's healthcare and research initiatives by providing a diverse array...
This is a federal contract award from the Defense Health Agency to Fenwal, Inc., a subsidiary of Fresenius Kabi, for the supply of centrifuge bags. The contract has a firm fixed price of $8,054.68 and a completion date of December 29, 2016. Fenwal, Inc. is an established vendor for the U.S. federal government, specializing in the development and manufacture of products and services for blood collection, separation, storage, and transfusion. This contract is not set aside and is part of Fenwal's broader work supporting various federal agencies, including the Department of Defense, Department of Veterans Affairs, and National Institutes of Health, in the areas of transfusion medicine and cell therapy.
Generated 3/29/25, 9:54 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | $8.1k | 3/13/17 | |
| Not listed | Not listed | $0 | 9/2/16 |